Skip to content

Comparison the effects of mannitol between at the time immediately after anesthesia induction and skin incision on brain relaxation in craniotomy

Comparison the effects of mannitol between at the time immediately after anesthesia induction and skin incision on brain relaxation in craniotomy, A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250224001
Enrollment
80
Registered
2025-02-24
Start date
2023-08-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mannitol is the treatment of choice for reducing intracranial pressure. the most commonly used concentration of mannitol is 20% at a dose of 1.0 g/kg, as it effectively reduces brain tension with minimal side effects. However, there are no definitive guidelines on the optimal timing for mannitol administration. mannitol,craniotomy,brain relaxation score

Interventions

received 20% mannitol dose 1.0 g/kg immediately after anesthesia induction ,patient received 20% mannitol dose 1.0 g/kg at the time of skin incision
Received immediately after anesthesia induction,Received at the time of skin incision

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients with brain tumors size less than 5 cm. undergoing elective craniotomy 2.Receive mannitol during surgery 3.Aged between 18 and 65 years 4.ASA physical status classification 1-3 5.Glasgow Coma Scale (GCS) score of 13-15

Exclusion criteria

Exclusion criteria: 1. Refuse to participate 2.Preoperative hyponatremia or hypernatremia (serum sodium < 120 or > 150 mmol/L) 3.Preoperative congestive heart failure or respiratory distress 4.Chronic kidney disease stage 3-5 (GFR < 60 mL/min/1.73 m2) 5.Treatment with mannitol, hypertonic saline or diuretics in the previous 24 hours 6.Patients who had undergone external ventricular drainage (EVD) or VP shunt

Design outcomes

Primary

MeasureTime frame
brain relaxation when dura opening brain relaxation score

Secondary

MeasureTime frame
Bispectral index T0: time at mannitol infusion T60: 60 minutes after mannitol infusion T120: 120 minutes after mannitol infusion monitor,Partial pressure carbon dioxide T0: time at mannitol infusion T60: 60 minutes after mannitol infusion T120: 120 minutes after mannitol infusion Showing 1 to 1 of 1 entries arterial blood gas,Intraoperative hemodynamic change: Heart rate, Mean arterial blood pressure, serum lactate, pulse pressure variation, urine output T0: time at mannitol infusion T60: 60 minutes after mannitol infusion T120: 120 minutes after mannitol infusion monitor, arterial blood gas,Incidence of severe electrolyte imbalance: serum sodium,resum potasssium, serum bicabonate T0: time at mannitol infusion T60: 60 minutes after mannitol infusion T120: 120 minutes after mannitol infusion Showing 1 to 1 of 1 entries arterial blood gas,Incidence of significant hemodynamic change T0: time at mannitol infusion T60: 60 minutes after mannitol infusion T120: 120 minutes after mannitol infusion monitor

Countries

Thailand

Contacts

Public ContactNapat Jaitham

Khon Kaen University

pimm.nj@gmail.com0982603513

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026